| Secondary |
| Product Used For Unknown Indication |
34.5% |
| Epilepsy |
24.6% |
| Partial Seizures |
9.1% |
| Ill-defined Disorder |
8.3% |
| Status Epilepticus |
8.1% |
| Constipation |
1.8% |
| Infection |
1.8% |
| Convulsion |
1.6% |
| Hypotension |
1.6% |
| Pyrexia |
1.6% |
| Insomnia |
1.2% |
| Brain Neoplasm |
1.0% |
| Prophylaxis |
1.0% |
| Gastroenteritis |
0.8% |
| Antifungal Prophylaxis |
0.6% |
| Hyperprolactinaemia |
0.6% |
| Myasthenia Gravis |
0.6% |
| Benign Prostatic Hyperplasia |
0.4% |
| Brain Oedema |
0.4% |
| Convulsion Prophylaxis |
0.4% |
|
| Tri-iodothyronine Decreased |
16.7% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
10.4% |
| Retinal Degeneration |
10.4% |
| Suicide Attempt |
8.3% |
| Toxic Epidermal Necrolysis |
8.3% |
| Depressed Level Of Consciousness |
4.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.2% |
| Gamma-glutamyltransferase Increased |
4.2% |
| Jaundice |
4.2% |
| Pancreatic Enzymes Increased |
4.2% |
| Urine Output Decreased |
4.2% |
| Vitamin D Deficiency |
4.2% |
| Blood Creatine Phosphokinase Increased |
2.1% |
| Drug Eruption |
2.1% |
| Drug Interaction |
2.1% |
| Generalised Erythema |
2.1% |
| Lymphocyte Stimulation Test Positive |
2.1% |
| Memory Impairment |
2.1% |
| Myasthenia Gravis |
2.1% |
| Purpura |
2.1% |
|
| Concomitant |
| Epilepsy |
41.2% |
| Product Used For Unknown Indication |
8.0% |
| Hypertension |
6.6% |
| Convulsion |
5.9% |
| Prophylaxis |
5.7% |
| Pneumonia |
3.8% |
| Insomnia |
3.7% |
| Complex Partial Seizures |
2.8% |
| Constipation |
2.8% |
| Simple Partial Seizures |
2.8% |
| Brain Neoplasm |
2.4% |
| Glioblastoma Multiforme |
2.3% |
| Bronchitis |
2.1% |
| Rasmussen Encephalitis |
2.1% |
| Depression |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Renal Cell Carcinoma |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Status Epilepticus |
1.2% |
| Cardiac Failure |
1.0% |
|
| Status Epilepticus |
9.9% |
| White Blood Cell Count Increased |
9.9% |
| White Blood Cell Count Decreased |
8.5% |
| Pneumonia |
7.0% |
| Pyrexia |
7.0% |
| Vomiting |
7.0% |
| Renal Failure Acute |
5.6% |
| Urinary Tract Infection |
5.6% |
| Cardio-respiratory Arrest |
4.2% |
| Convulsion |
4.2% |
| Sepsis |
4.2% |
| Urine Output Decreased |
4.2% |
| Choreoathetosis |
2.8% |
| Cyanosis |
2.8% |
| Delirium |
2.8% |
| Encephalitis Viral |
2.8% |
| Fracture |
2.8% |
| Lower Limb Fracture |
2.8% |
| Mobility Decreased |
2.8% |
| Neoplasm Malignant |
2.8% |
|
| Interacting |
| Epilepsy |
50.0% |
| Convulsion |
25.0% |
| Lennox-gastaut Syndrome |
12.5% |
| Colon Cancer |
4.7% |
| Injury |
4.7% |
| Hyperammonaemia |
3.1% |
|
| Intestinal Perforation |
80.0% |
| Status Epilepticus |
10.0% |
| Vomiting |
7.5% |
| Visual Impairment |
2.5% |
|
